Robert Roach Jr.
Concepts (321)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Altitude Sickness | 41 | 2011 | 172 | 5.070 |
Why?
| Cerebrovascular Circulation | 14 | 2011 | 221 | 2.590 |
Why?
| Altitude | 30 | 2011 | 432 | 2.170 |
Why?
| Hypoxia | 32 | 2011 | 956 | 2.150 |
Why?
| Oxygen Consumption | 16 | 2011 | 588 | 1.760 |
Why?
| Exercise | 16 | 2012 | 1644 | 1.410 |
Why?
| Mountaineering | 11 | 2011 | 47 | 1.400 |
Why?
| Carbon Dioxide | 12 | 2012 | 218 | 1.140 |
Why?
| Pulmonary Ventilation | 6 | 2009 | 72 | 0.980 |
Why?
| Acclimatization | 10 | 2010 | 149 | 0.890 |
Why?
| Acute Disease | 23 | 2011 | 910 | 0.840 |
Why?
| Oxygen | 18 | 2012 | 854 | 0.800 |
Why?
| Atmospheric Pressure | 4 | 2010 | 18 | 0.670 |
Why?
| Brain Edema | 6 | 2011 | 60 | 0.640 |
Why?
| Acetazolamide | 7 | 2011 | 30 | 0.630 |
Why?
| Water-Electrolyte Balance | 5 | 2005 | 26 | 0.560 |
Why?
| Pulmonary Edema | 12 | 2010 | 115 | 0.550 |
Why?
| Respiration | 11 | 2010 | 179 | 0.550 |
Why?
| Pulmonary Gas Exchange | 11 | 2012 | 117 | 0.540 |
Why?
| Headache | 5 | 2011 | 132 | 0.540 |
Why?
| Quadriceps Muscle | 2 | 2007 | 104 | 0.530 |
Why?
| Middle Cerebral Artery | 4 | 2010 | 37 | 0.500 |
Why?
| Physical Exertion | 4 | 2007 | 209 | 0.470 |
Why?
| Muscle Contraction | 2 | 2007 | 389 | 0.470 |
Why?
| Adaptation, Physiological | 5 | 2011 | 483 | 0.460 |
Why?
| Adult | 54 | 2012 | 30514 | 0.450 |
Why?
| Rest | 2 | 2012 | 103 | 0.440 |
Why?
| Regional Blood Flow | 7 | 2011 | 424 | 0.440 |
Why?
| Dexamethasone | 3 | 2011 | 317 | 0.420 |
Why?
| Muscle Fatigue | 3 | 2008 | 94 | 0.400 |
Why?
| Hypoxia, Brain | 2 | 2011 | 10 | 0.390 |
Why?
| Spectroscopy, Near-Infrared | 5 | 2010 | 47 | 0.390 |
Why?
| Homeostasis | 4 | 2011 | 573 | 0.380 |
Why?
| Cell Membrane Permeability | 1 | 2011 | 83 | 0.370 |
Why?
| Hyperoxia | 2 | 2010 | 99 | 0.350 |
Why?
| Blood Flow Velocity | 6 | 2011 | 387 | 0.340 |
Why?
| Ultrasonography, Doppler, Transcranial | 5 | 2010 | 42 | 0.340 |
Why?
| Intracranial Pressure | 2 | 2008 | 48 | 0.340 |
Why?
| Physical Endurance | 2 | 2008 | 232 | 0.340 |
Why?
| Male | 53 | 2012 | 55534 | 0.330 |
Why?
| Single-Blind Method | 4 | 2012 | 258 | 0.330 |
Why?
| Selection, Genetic | 1 | 2011 | 242 | 0.320 |
Why?
| Blood Pressure | 6 | 2011 | 1538 | 0.320 |
Why?
| Radial Artery | 1 | 2009 | 66 | 0.320 |
Why?
| Cross-Over Studies | 4 | 2012 | 440 | 0.310 |
Why?
| Motor Cortex | 1 | 2009 | 47 | 0.310 |
Why?
| Humans | 73 | 2012 | 114599 | 0.300 |
Why?
| Competitive Behavior | 1 | 2008 | 39 | 0.300 |
Why?
| Water-Electrolyte Imbalance | 2 | 2005 | 26 | 0.300 |
Why?
| Optic Nerve | 1 | 2008 | 65 | 0.290 |
Why?
| Respiratory Mechanics | 1 | 2007 | 56 | 0.290 |
Why?
| Frontal Lobe | 1 | 2007 | 140 | 0.270 |
Why?
| Prefrontal Cortex | 1 | 2009 | 262 | 0.260 |
Why?
| Body Fluids | 2 | 2005 | 58 | 0.250 |
Why?
| Young Adult | 10 | 2012 | 10452 | 0.240 |
Why?
| Carbonic Anhydrase Inhibitors | 3 | 2011 | 17 | 0.240 |
Why?
| Female | 39 | 2011 | 59446 | 0.240 |
Why?
| Contraceptives, Oral | 2 | 2001 | 25 | 0.240 |
Why?
| Models, Cardiovascular | 3 | 2011 | 178 | 0.230 |
Why?
| Exercise Test | 3 | 2012 | 544 | 0.230 |
Why?
| Cerebral Cortex | 1 | 2007 | 380 | 0.230 |
Why?
| Heart Rate | 5 | 2010 | 709 | 0.220 |
Why?
| Double-Blind Method | 7 | 2011 | 1660 | 0.220 |
Why?
| Autonomic Nervous System | 2 | 2003 | 66 | 0.220 |
Why?
| Cardiac Output | 4 | 2008 | 143 | 0.220 |
Why?
| Tidal Volume | 3 | 2012 | 75 | 0.210 |
Why?
| Severity of Illness Index | 4 | 2009 | 2537 | 0.200 |
Why?
| Respiratory Physiological Phenomena | 2 | 2003 | 29 | 0.200 |
Why?
| Body Temperature | 1 | 2003 | 208 | 0.200 |
Why?
| Research Design | 1 | 2007 | 928 | 0.180 |
Why?
| Inflammation | 1 | 2011 | 2477 | 0.180 |
Why?
| Leg | 3 | 1999 | 225 | 0.180 |
Why?
| Blood Gas Analysis | 5 | 2012 | 72 | 0.180 |
Why?
| Hemoglobins | 5 | 2011 | 315 | 0.160 |
Why?
| Cardiovascular System | 2 | 1997 | 125 | 0.160 |
Why?
| Brain | 4 | 2011 | 2371 | 0.160 |
Why?
| Vasodilation | 2 | 1999 | 419 | 0.150 |
Why?
| Vasoconstriction | 2 | 1999 | 177 | 0.150 |
Why?
| Knee | 1 | 1997 | 51 | 0.140 |
Why?
| Blood-Brain Barrier | 2 | 2011 | 106 | 0.130 |
Why?
| Atmosphere Exposure Chambers | 2 | 1996 | 6 | 0.130 |
Why?
| Muscles | 1 | 1997 | 320 | 0.130 |
Why?
| Time Factors | 4 | 2010 | 6112 | 0.130 |
Why?
| Physical Fitness | 2 | 1995 | 179 | 0.120 |
Why?
| Arginine Vasopressin | 3 | 2005 | 46 | 0.120 |
Why?
| Travel | 3 | 2007 | 121 | 0.110 |
Why?
| Predictive Value of Tests | 2 | 2009 | 1796 | 0.110 |
Why?
| Analysis of Variance | 4 | 2011 | 1226 | 0.110 |
Why?
| Muscle, Skeletal | 3 | 1999 | 1472 | 0.100 |
Why?
| Diagnosis, Differential | 2 | 2011 | 1342 | 0.100 |
Why?
| Validation Studies as Topic | 1 | 2012 | 23 | 0.100 |
Why?
| Disease Susceptibility | 2 | 2008 | 316 | 0.100 |
Why?
| Hyperbaric Oxygenation | 1 | 1991 | 36 | 0.100 |
Why?
| Tibet | 1 | 2011 | 28 | 0.090 |
Why?
| Blood Circulation Time | 1 | 2010 | 3 | 0.090 |
Why?
| Life Expectancy | 1 | 2011 | 51 | 0.090 |
Why?
| Treatment Outcome | 3 | 2011 | 9084 | 0.090 |
Why?
| Constriction | 1 | 2010 | 45 | 0.090 |
Why?
| Bicycling | 1 | 2011 | 86 | 0.090 |
Why?
| Energy Metabolism | 2 | 2002 | 731 | 0.090 |
Why?
| Vasomotor System | 1 | 2010 | 39 | 0.090 |
Why?
| Cerebral Arteries | 1 | 2011 | 55 | 0.090 |
Why?
| Hypertension, Pregnancy-Induced | 1 | 2011 | 45 | 0.090 |
Why?
| Uterine Artery | 1 | 2011 | 67 | 0.090 |
Why?
| Gene Frequency | 1 | 2011 | 477 | 0.080 |
Why?
| Vascular Resistance | 1 | 2011 | 337 | 0.080 |
Why?
| Fourier Analysis | 1 | 2009 | 39 | 0.080 |
Why?
| Oxygen Inhalation Therapy | 2 | 2010 | 129 | 0.080 |
Why?
| Myocardial Ischemia | 1 | 2011 | 235 | 0.080 |
Why?
| Reaction Time | 1 | 2011 | 376 | 0.080 |
Why?
| Manometry | 1 | 2009 | 89 | 0.080 |
Why?
| Norepinephrine | 4 | 2008 | 201 | 0.080 |
Why?
| Dinoprost | 1 | 2009 | 31 | 0.080 |
Why?
| Anticonvulsants | 1 | 2011 | 179 | 0.080 |
Why?
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2011 | 225 | 0.080 |
Why?
| Anaerobic Threshold | 1 | 2009 | 22 | 0.080 |
Why?
| Pre-Eclampsia | 1 | 2011 | 165 | 0.080 |
Why?
| Ventilators, Mechanical | 1 | 2009 | 52 | 0.080 |
Why?
| Chronic Disease | 4 | 2007 | 1578 | 0.080 |
Why?
| Respiratory Function Tests | 2 | 2008 | 522 | 0.070 |
Why?
| Risk Factors | 6 | 2004 | 8624 | 0.070 |
Why?
| Inhalation | 1 | 2007 | 26 | 0.070 |
Why?
| Anti-Inflammatory Agents | 1 | 2011 | 447 | 0.070 |
Why?
| Exhalation | 1 | 2007 | 35 | 0.070 |
Why?
| Epidemiologic Methods | 1 | 2008 | 72 | 0.070 |
Why?
| Acid-Base Equilibrium | 2 | 2001 | 29 | 0.070 |
Why?
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2009 | 249 | 0.070 |
Why?
| Oxyhemoglobins | 1 | 2007 | 20 | 0.070 |
Why?
| Blood Volume | 1 | 2007 | 59 | 0.070 |
Why?
| Anemia | 2 | 1999 | 143 | 0.070 |
Why?
| Cause of Death | 1 | 2008 | 361 | 0.070 |
Why?
| Sports Medicine | 1 | 2008 | 104 | 0.070 |
Why?
| Leukocytes, Mononuclear | 1 | 2009 | 493 | 0.070 |
Why?
| Genomics | 1 | 2011 | 635 | 0.070 |
Why?
| Reproducibility of Results | 2 | 2007 | 2761 | 0.070 |
Why?
| Epinephrine | 3 | 2008 | 163 | 0.070 |
Why?
| Activities of Daily Living | 1 | 1989 | 348 | 0.070 |
Why?
| Genotype | 1 | 2011 | 1760 | 0.070 |
Why?
| Fetal Growth Retardation | 1 | 2011 | 467 | 0.060 |
Why?
| Lactic Acid | 3 | 2009 | 275 | 0.060 |
Why?
| Condiments | 1 | 1985 | 1 | 0.060 |
Why?
| Recovery of Function | 1 | 2009 | 573 | 0.060 |
Why?
| Bolivia | 2 | 2011 | 62 | 0.060 |
Why?
| Prospective Studies | 3 | 2008 | 6214 | 0.060 |
Why?
| Models, Biological | 1 | 2012 | 1620 | 0.060 |
Why?
| Biomedical Research | 1 | 2011 | 585 | 0.060 |
Why?
| Riboflavin Deficiency | 1 | 1984 | 1 | 0.060 |
Why?
| Riboflavin | 1 | 1984 | 7 | 0.060 |
Why?
| Nausea | 2 | 2001 | 101 | 0.060 |
Why?
| Ultrasonography | 1 | 2008 | 633 | 0.060 |
Why?
| Catecholamines | 2 | 2003 | 94 | 0.060 |
Why?
| Migraine with Aura | 1 | 2004 | 10 | 0.060 |
Why?
| Environmental Exposure | 1 | 2008 | 372 | 0.060 |
Why?
| Kidney | 2 | 2002 | 1187 | 0.060 |
Why?
| Gait Ataxia | 1 | 2004 | 5 | 0.060 |
Why?
| Consciousness Disorders | 1 | 2004 | 19 | 0.060 |
Why?
| Biomarkers | 2 | 2011 | 3405 | 0.060 |
Why?
| Posture | 3 | 1993 | 152 | 0.060 |
Why?
| Middle Aged | 8 | 2008 | 26705 | 0.060 |
Why?
| Neurologic Examination | 1 | 2004 | 114 | 0.050 |
Why?
| Pulmonary Disease, Chronic Obstructive | 1 | 2011 | 913 | 0.050 |
Why?
| Nifedipine | 2 | 2001 | 29 | 0.050 |
Why?
| Antacids | 1 | 1983 | 15 | 0.050 |
Why?
| Bed Rest | 2 | 1993 | 15 | 0.050 |
Why?
| Kidney Function Tests | 2 | 2002 | 140 | 0.050 |
Why?
| Primary Prevention | 1 | 2005 | 172 | 0.050 |
Why?
| Steroids | 1 | 2004 | 144 | 0.050 |
Why?
| Body Weight | 2 | 2002 | 868 | 0.050 |
Why?
| Stroke | 1 | 2011 | 1021 | 0.050 |
Why?
| DNA | 1 | 2009 | 1351 | 0.050 |
Why?
| Algorithms | 1 | 2009 | 1466 | 0.050 |
Why?
| Health Education | 1 | 2005 | 323 | 0.050 |
Why?
| Urine | 1 | 2001 | 54 | 0.050 |
Why?
| Follicular Phase | 1 | 2001 | 36 | 0.050 |
Why?
| Environmental Medicine | 1 | 2001 | 1 | 0.050 |
Why?
| Diuretics | 1 | 2001 | 66 | 0.050 |
Why?
| Luteal Phase | 1 | 2001 | 41 | 0.050 |
Why?
| Calcium Channel Blockers | 1 | 2001 | 114 | 0.050 |
Why?
| Drinking | 1 | 2000 | 33 | 0.040 |
Why?
| Urination | 1 | 2000 | 40 | 0.040 |
Why?
| Adolescent | 4 | 2011 | 17827 | 0.040 |
Why?
| Child Welfare | 1 | 2001 | 192 | 0.040 |
Why?
| Surveys and Questionnaires | 1 | 2010 | 4618 | 0.040 |
Why?
| Smoking | 1 | 1985 | 1380 | 0.040 |
Why?
| Neoplasms | 1 | 2011 | 2097 | 0.040 |
Why?
| Air Pressure | 1 | 1997 | 4 | 0.040 |
Why?
| Spirometry | 2 | 1995 | 224 | 0.040 |
Why?
| Arteries | 1 | 1999 | 247 | 0.030 |
Why?
| Sympathetic Nervous System | 1 | 1998 | 171 | 0.030 |
Why?
| Environment, Controlled | 1 | 1996 | 19 | 0.030 |
Why?
| Aerospace Medicine | 1 | 1996 | 19 | 0.030 |
Why?
| Atrial Natriuretic Factor | 3 | 2005 | 55 | 0.030 |
Why?
| Sex Characteristics | 1 | 2001 | 640 | 0.030 |
Why?
| Chemoreceptor Cells | 1 | 1996 | 55 | 0.030 |
Why?
| Mathematics | 2 | 2002 | 101 | 0.030 |
Why?
| Sensitivity and Specificity | 1 | 1998 | 1691 | 0.030 |
Why?
| Partial Pressure | 2 | 1998 | 30 | 0.030 |
Why?
| Age Factors | 2 | 1998 | 2893 | 0.030 |
Why?
| Acid-Base Imbalance | 1 | 1993 | 5 | 0.030 |
Why?
| Aged, 80 and over | 3 | 2011 | 6344 | 0.030 |
Why?
| Renin | 2 | 2005 | 31 | 0.030 |
Why?
| Aldosterone | 2 | 2005 | 42 | 0.030 |
Why?
| Peru | 2 | 2004 | 54 | 0.030 |
Why?
| Hemodynamics | 3 | 1993 | 1012 | 0.030 |
Why?
| Lung | 3 | 1992 | 3557 | 0.030 |
Why?
| Coronary Disease | 1 | 1995 | 348 | 0.030 |
Why?
| Obesity | 1 | 1984 | 2507 | 0.020 |
Why?
| Benzolamide | 1 | 1991 | 1 | 0.020 |
Why?
| Pilot Projects | 1 | 1996 | 1371 | 0.020 |
Why?
| Lung Diseases | 2 | 1995 | 701 | 0.020 |
Why?
| Child | 3 | 2008 | 18401 | 0.020 |
Why?
| Dogs | 2 | 2008 | 334 | 0.020 |
Why?
| Laser-Doppler Flowmetry | 1 | 2011 | 32 | 0.020 |
Why?
| Live Birth | 1 | 2011 | 48 | 0.020 |
Why?
| Iliac Artery | 1 | 2011 | 43 | 0.020 |
Why?
| Aged | 4 | 2011 | 19056 | 0.020 |
Why?
| Vasodilator Agents | 1 | 1992 | 302 | 0.020 |
Why?
| Stillbirth | 1 | 2011 | 57 | 0.020 |
Why?
| Heart Septal Defects, Atrial | 1 | 1991 | 51 | 0.020 |
Why?
| Ultrasonography, Doppler | 1 | 2011 | 105 | 0.020 |
Why?
| Hydrogen-Ion Concentration | 3 | 1998 | 511 | 0.020 |
Why?
| Ultrasonography, Prenatal | 1 | 2011 | 235 | 0.020 |
Why?
| Pulse | 1 | 2009 | 27 | 0.020 |
Why?
| Succinic Acid | 1 | 2009 | 44 | 0.020 |
Why?
| Weather | 1 | 2008 | 24 | 0.020 |
Why?
| Death, Sudden | 1 | 2008 | 27 | 0.020 |
Why?
| Free Radicals | 1 | 2009 | 99 | 0.020 |
Why?
| Hypothermia | 1 | 2008 | 38 | 0.020 |
Why?
| Osmolar Concentration | 2 | 2002 | 173 | 0.020 |
Why?
| Gestational Age | 1 | 2011 | 759 | 0.020 |
Why?
| Statistics as Topic | 1 | 1989 | 292 | 0.020 |
Why?
| Stimulation, Chemical | 1 | 1987 | 56 | 0.020 |
Why?
| Premature Birth | 1 | 2011 | 276 | 0.020 |
Why?
| Glutathione | 1 | 2009 | 293 | 0.020 |
Why?
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2009 | 238 | 0.020 |
Why?
| Hypertension | 1 | 1995 | 1056 | 0.020 |
Why?
| Monitoring, Physiologic | 1 | 1989 | 249 | 0.020 |
Why?
| Accidental Falls | 1 | 2008 | 150 | 0.020 |
Why?
| Databases, Factual | 1 | 2011 | 1124 | 0.020 |
Why?
| Sleep Apnea Syndromes | 1 | 1987 | 74 | 0.020 |
Why?
| Energy Intake | 1 | 1989 | 427 | 0.020 |
Why?
| Electrocardiography | 1 | 1989 | 560 | 0.020 |
Why?
| Vital Capacity | 2 | 1983 | 255 | 0.020 |
Why?
| New Mexico | 1 | 2005 | 59 | 0.020 |
Why?
| Glutathione Reductase | 1 | 1984 | 21 | 0.010 |
Why?
| Piperazines | 1 | 1987 | 309 | 0.010 |
Why?
| Positive-Pressure Respiration | 1 | 1985 | 68 | 0.010 |
Why?
| Cross-Sectional Studies | 2 | 2011 | 4404 | 0.010 |
Why?
| Metabolomics | 1 | 2009 | 521 | 0.010 |
Why?
| Nutritional Requirements | 1 | 1984 | 75 | 0.010 |
Why?
| Diet, Reducing | 1 | 1984 | 76 | 0.010 |
Why?
| International Cooperation | 1 | 2005 | 171 | 0.010 |
Why?
| Case-Control Studies | 1 | 2011 | 3001 | 0.010 |
Why?
| Protein Binding | 1 | 2009 | 1888 | 0.010 |
Why?
| Indians, South American | 1 | 2003 | 22 | 0.010 |
Why?
| Sleep | 2 | 2003 | 631 | 0.010 |
Why?
| Oxidative Stress | 1 | 2009 | 1076 | 0.010 |
Why?
| Polycythemia | 1 | 2003 | 23 | 0.010 |
Why?
| Washington | 1 | 1983 | 134 | 0.010 |
Why?
| Hypertonic Solutions | 1 | 2002 | 7 | 0.010 |
Why?
| Erythropoietin | 1 | 2003 | 72 | 0.010 |
Why?
| Clinical Trials as Topic | 2 | 1983 | 931 | 0.010 |
Why?
| Sodium Chloride | 1 | 2002 | 136 | 0.010 |
Why?
| Infusions, Intravenous | 1 | 2002 | 371 | 0.010 |
Why?
| Societies, Medical | 1 | 2005 | 663 | 0.010 |
Why?
| Body Composition | 1 | 1984 | 590 | 0.010 |
Why?
| Endothelin-1 | 1 | 2002 | 167 | 0.010 |
Why?
| Creatinine | 1 | 2002 | 425 | 0.010 |
Why?
| Pulmonary Circulation | 2 | 1992 | 407 | 0.010 |
Why?
| Circadian Rhythm | 1 | 2003 | 354 | 0.010 |
Why?
| Erythrocytes | 1 | 1984 | 591 | 0.010 |
Why?
| Regression Analysis | 2 | 1993 | 944 | 0.010 |
Why?
| Pregnancy | 1 | 2011 | 5516 | 0.010 |
Why?
| Nitric Oxide | 1 | 2004 | 822 | 0.010 |
Why?
| Ergometry | 1 | 1998 | 4 | 0.010 |
Why?
| Disease Models, Animal | 1 | 2008 | 3531 | 0.010 |
Why?
| Peptide Fragments | 1 | 2002 | 665 | 0.010 |
Why?
| Femoral Vein | 1 | 1997 | 28 | 0.010 |
Why?
| Pulmonary Alveoli | 2 | 1992 | 373 | 0.010 |
Why?
| Therapeutic Irrigation | 2 | 1988 | 67 | 0.010 |
Why?
| Glucose | 1 | 2002 | 896 | 0.010 |
Why?
| Patient Education as Topic | 1 | 2001 | 680 | 0.010 |
Why?
| United States | 1 | 2011 | 12167 | 0.010 |
Why?
| Random Allocation | 2 | 1987 | 335 | 0.010 |
Why?
| Methods | 1 | 1993 | 58 | 0.010 |
Why?
| Lactates | 1 | 1993 | 79 | 0.010 |
Why?
| Ocular Physiological Phenomena | 1 | 1993 | 11 | 0.010 |
Why?
| Plasma Volume | 1 | 1993 | 13 | 0.010 |
Why?
| Electrolytes | 1 | 1993 | 55 | 0.010 |
Why?
| Phentolamine | 1 | 1992 | 14 | 0.010 |
Why?
| Hydralazine | 1 | 1992 | 5 | 0.010 |
Why?
| Dinitrophenols | 1 | 1992 | 7 | 0.010 |
Why?
| 2,4-Dinitrophenol | 1 | 1992 | 8 | 0.010 |
Why?
| Ventilation-Perfusion Ratio | 1 | 1992 | 9 | 0.010 |
Why?
| Psychological Tests | 1 | 1993 | 120 | 0.010 |
Why?
| Hyperventilation | 1 | 1992 | 8 | 0.010 |
Why?
| Retrospective Studies | 1 | 2008 | 12541 | 0.010 |
Why?
| Echocardiography, Doppler | 1 | 1992 | 91 | 0.010 |
Why?
| Periodicity | 1 | 1991 | 55 | 0.010 |
Why?
| Proteins | 2 | 1988 | 908 | 0.010 |
Why?
| Decompression | 1 | 1990 | 3 | 0.010 |
Why?
| Animals | 2 | 2008 | 31692 | 0.010 |
Why?
| Acidosis | 1 | 1991 | 88 | 0.010 |
Why?
| Hypercapnia | 1 | 1990 | 51 | 0.010 |
Why?
| Infant, Newborn | 1 | 2001 | 5040 | 0.010 |
Why?
| Glomerular Filtration Rate | 1 | 1993 | 604 | 0.010 |
Why?
| Echocardiography | 1 | 1991 | 553 | 0.000 |
Why?
| Infant | 1 | 2001 | 7954 | 0.000 |
Why?
| Almitrine | 1 | 1987 | 1 | 0.000 |
Why?
| Child, Preschool | 1 | 2001 | 9106 | 0.000 |
Why?
| Incidence | 1 | 1993 | 2311 | 0.000 |
Why?
| Bronchi | 1 | 1988 | 231 | 0.000 |
Why?
| Reference Values | 1 | 1988 | 742 | 0.000 |
Why?
| Leukotriene B4 | 1 | 1986 | 48 | 0.000 |
Why?
| Chemotactic Factors | 1 | 1986 | 50 | 0.000 |
Why?
| Hydroxyeicosatetraenoic Acids | 1 | 1986 | 40 | 0.000 |
Why?
| Molecular Weight | 1 | 1986 | 331 | 0.000 |
Why?
| Permeability | 1 | 1986 | 149 | 0.000 |
Why?
| Cell Count | 1 | 1986 | 303 | 0.000 |
Why?
| Lung Volume Measurements | 1 | 1985 | 45 | 0.000 |
Why?
| Colorado | 1 | 1993 | 4099 | 0.000 |
Why?
|
|
Roach Jr.'s Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|